{
    "paper_id": "1444c59f6e2f0b739c509c800ef58f4f5f6402ea",
    "metadata": {
        "title": "Position Statement on the Management of 4 Cardiac Electrophysiology and Cardiac 5 Implantable Electronic Devices in Australia",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "vices [1] . 98 In response to this pandemic, the Cardiac Society of 99 Australia and New Zealand (CSANZ) Board requested the 100 Heart Rhythm Council rapidly produce a ''live\" document to 101 provide guidance to its members for the practice of EP and 102 CIED services in Australia. The document takes into account 103 published grey papers from international societies and 104 advice from key opinion leaders within Australia and over-105 seas, with frequent updates to adapt to the evolving pan-106 demic and its impact on the Australian health system.",
            "cite_spans": [
                {
                    "start": 6,
                    "end": 9,
                    "text": "[1]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 12,
                    "end": 14,
                    "text": "98",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The guidelines provide a framework for implementing 108 services during the pandemic. It is noted that the practice 109 of EP and CIED management in Australia is varied amongst 110 public and private hospitals, regional and remote areas, and 111 in outreach clinics. The application of these recommenda-112 tions will therefore need to be tailored to local models of 113 service delivery. 114 In response to the CSANZ board request, the Chair of the 115 Heart Rhythm Council summoned the formation of the Heart 116 Rhythm Council COVID-19 Pandemic working group. The 117 group is formed by the authors listed in this document, 118 whose responsibility it was to contribute to the original 119 source document, and who will continue provide frequent 120 updates in six Domains: 121 1 Implementing a Framework for Altered Services.",
            "cite_spans": [
                {
                    "start": 389,
                    "end": 392,
                    "text": "114",
                    "ref_id": null
                },
                {
                    "start": 777,
                    "end": 780,
                    "text": "121",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "107"
        },
        {
            "text": "The COVID-19 pandemic poses a significant stress on health resources in Australia. The Heart Rhythm Council of the Cardiac Society of Australia and New Zealand aims to provide a framework for efficient resource utilisation balanced with competing risks when appropriately treating patients with cardiac arrhythmias. This document provides practical recommendations for the electrophysiology (EP) and cardiac implantable electronic devices (CIED) services in Australia. The document will be updated regularly as new evidence and knowledge is gained with time.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "107"
        },
        {
            "text": "COVID-19 cardiac electrophysiology cardiac implantable electronic devices personal protective equipment congenital heart disease appointment. Ideally, these remote clinics will occur in a 261 location distant to areas exposed to direct patient contact. Although small studies and anecdotal reports suggest 508 that these may be useful, large scale randomised con-509 trolled data is lacking. The use of heart rate monitors (e.g.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Keywords"
        },
        {
            "text": "Fitbit, Garmin watch) are unlikely to be useful in this 511 setting and is discouraged. in one third of patients admitted to ICU [6] . to reduce viral load [14] . Azithromycin has anti-inflamma-798 tory effects and is an antibiotic which may cause long QT and 799 Torsade de Pointes. Case reports exist for potentiation of long 800 QT in patients with hypokalaemia and with co-administra-801 tion of other QT prolonging drugs, e.g, chloroquine [15] . ",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 132,
                    "text": "[6]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 156,
                    "end": 160,
                    "text": "[14]",
                    "ref_id": null
                },
                {
                    "start": 444,
                    "end": 448,
                    "text": "[15]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "510"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Domain 4, EP and CIED Procedural Considerations: Jona-1020 than Kalman",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Online ahead of print",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Lakkireddy",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gopinathannair",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "K"
                    ],
                    "last": "Patton",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Gluckman",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1161/CIRCULATIONAHA.120.047063"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Consensus 1038 guidelines for Interventional Cardiology services delivery during 1039",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Lo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Yong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sinhal",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shetty",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mccann",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "COVID-19 pandemic in Australia and New Zealand",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "29",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "1042 et al. The Heart Rhythm Society (HRS)/American Society of Anesthesi-1043 ologists (ASA) Expert Consensus Statement on the perioperative man-(STS)",
            "authors": [
                {
                    "first": "Crossley",
                    "middle": [],
                    "last": "Gh",
                    "suffix": ""
                },
                {
                    "first": "Poole",
                    "middle": [],
                    "last": "Je",
                    "suffix": ""
                },
                {
                    "first": "Rozner",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "Asirvatham",
                    "middle": [],
                    "last": "Sj",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "Chung",
                    "middle": [],
                    "last": "Mk",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Heart Rhythm",
            "volume": "8",
            "issn": "",
            "pages": "1114--54",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Random-1051 ized controlled trial of perioperative ICD management: magnet applica-1052 tion versus reprogramming",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gifford",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Larimer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "May",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stanhope",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gami",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Pacing Clin Electrophysiol",
            "volume": "37",
            "issn": "",
            "pages": "1219--1243",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Remdesivir and 1054 chloroquine effectively inhibit the recently emerged novel coronavirus 1055 (2019-nCoV) in vitro",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Cell Res",
            "volume": "30",
            "issn": "",
            "pages": "269--71",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "COVID-19 and the cardiovascular 1057 system",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Nat Rev Cardiol",
            "volume": "17",
            "issn": "",
            "pages": "259--60",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Characteristics and Outcomes of 21 Critically Ill Patients With",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Cardiovascular complications of severe acute respiratory syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Case-fatality rate and characteristics of 1065 patients dying in relation to COVID-19 in Italy",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Onder",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rezza",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Brusaferro",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA )",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.4683"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Online ahead of print",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.4683"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Coronaviruses and the 1068 cardiovascular system: acute and long-term implications",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "Y"
                    ],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Redwood",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Prendergast",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Eur Heart J",
            "volume": "1069",
            "issn": "2020",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/eurheartj/ehaa231"
                ]
            }
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Online ahead of print",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "factors for mortality of adult inpatients with COVID-19 in Wuhan, China: 1073 a retrospective cohort study",
            "authors": [],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Cardiovascular 1075 implications of fatal outcomes of patients with coronavirus disease",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "COVID-19)",
            "authors": [],
            "year": null,
            "venue": "JAMA Cardiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jamacardio.2020.1017"
                ]
            }
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: 1083 results of an open-label non-randomized clinical trial",
            "authors": [],
            "year": null,
            "venue": "Int J Antimicrob",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "vascular risks with azithromycin and other antibacterial drugs",
            "authors": [],
            "year": 2013,
            "venue": "N Engl J 1087 Med",
            "volume": "368",
            "issn": "",
            "pages": "1665--1673",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "ance for navigating and circumventing the QTc prolonging and torsado-1090",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "genic potential of possible pharmacotherapies for COVID-19",
            "authors": [],
            "year": null,
            "venue": "Mayo Clin",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Proc 2020",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "SARS-CoV-2 Infection in 1093",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Y"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Clinical 1095 characteristics of children with coronavirus disease",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "Q-H",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "H-B",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "X-G",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Z-G",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Clinical characteristics of novel 1098",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H-T",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "C-J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "COVID-19) in newborns, infants and children",
            "authors": [],
            "year": null,
            "venue": "coronavirus disease 2019",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "female infant infected with COVID 19: presenting with pneumonia, liver",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "beginning of a pandemic that has had a major 85 impact on health care systems around the world. SARS-Cov-86 2 causes a pneumonic respiratory illness known as COVID-87 19, with the potential for severe cardiovascular damage. The 88 high infectivity rate has led to rapid escalation of cases 89 around the world. COVID-19 demonstrates a higher mortal-90 ity rate amongst patients with pre-existing illness, especially 91 those with cardiovascular disease. This has prompted a rapid 92 evaluation of routine cardiac electrophysiology (EP) and 93 cardiac implantable electronic devices (CIED) services within 94 Australia. Major international societies (Heart Rhythm Soci-95 ety, British Heart Rhythm Society), have urgently released 96 guidelines as live documents for the provision of such ser-97",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "We recognise that such infrastructure may not exist in 186 private practices but advise that a framework be estab-187 lished within one or more partners within the group, and 188 with the host hospital where consultation and proce-189 dures are performed. Where not possible or practical, 190 such as in the instance of solo practitioners, we advise 191 that the group could adhere to the majority of these 192 recommendations, as far as practically feasible. Teleconferencing is recommended to avoid cross infec-194 tion of the leadership group.195 7 We recommend networks nominate a group leader 196 within the network who will coordinate and implement 197 the action plan, and an assistant lead who should mon-198 itor national and global trends closely, and adapt these, 199 where feasible, to local and national recommendations.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "We recommend the nomination of a triaging lead phy-201 sician (1 EP, 1 CIED program) who works with a triage 202 nurse or allied health staff member to review clinical 203 need and urgency of elective procedures. 204 9 We recommend that non-urgent elective cardiac electro-205 physiology and CIED implant procedures be deferred to 206 preserve resources for urgent cases and to allow cathe-207 terisation labs time to prepare for the use of PPE. We 208 suggest inpatient procedures be performed as quickly as 209 possible, if they cannot be deferred for a minimum of 1-3 210 months. 211 10 We suggest that all outpatient consultations should be 212 altered to telephone or teleconference as soon as possible 213 to reduce in-person interaction of vulnerable patients 214 and/or vulnerable physicians. If feasible, outpatient ser-215 vices should remain to support general practices and 216 emergency department (ED) referrals. We suggest that allied health staff responsible for EP and 235 CIED services could be divided into ''lab based\" vs ''clinical 236 based\" teams using a rotational roster, whereby teams are not 237 in physical contact with each other. These teams should be 238 kept separate, at all times, either via rostered location or 239 rostered times with: 240 a. Clinical-based teams performing, where feasible, 241 duties from a site remote to areas exposed to direct patient 242 contact. 243 b. Lab-based teams performing duties that involve 244 direct patient contact. 245 c. Teams designed to best conserve skill and leader-246 ship and have sufficient competence to perform in-person 247 and remote CIED interrogations, independently of the other 248 teams, in the event that there is a necessity to isolate one 249 team. 250 2. Potential tasks/activities for a clinical based team(s) 251 could include: 252 a. To support scheduled outpatient CIED clinics via 253 teleconferencing, if feasible. These clinics will provide con-254 tinuing patient education and support. It further aims to 255 avoid unnecessary hospitalisations and in-person visits, 256 thereby reducing the burden on the hospital system and 257 reducing infection risk for patients and staff. Patients with 258 remote monitoring should have downloads scheduled to 259 synchronise with their originally scheduled face-to-face260",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "In the rare instance that ambulatory Holter monitoring513    and/or stress testing is the ONLY option for investiga-514 tion of a patient, advice listed in Item 7 of Domain 1 above 515 should be followed. Equipment must undergo a thor-516 ough clean before and after each use using hospital 517 approved disinfectants that are active against COVID-518 19. For handling those Holters, department/practices 519 should have a working policy. While Holter monitors 520 can be shipped and returned through the post, issues 521 related to damage and loss should be considered. noted in Domain 1, the practice of EP and CIED in 526 Australia is variable amongst local health districts, and in 527 regional and remote areas. These guidelines are not man-528 dated but intend to provide a framework for rationalising 529 outpatient procedures. We encourage that members use 530 these recommendations, and tailor recommendations to 531 local demands for EP and CIED services, models of service 532 delivery, local outbreak patterns, local hospital recommen-533 dations, PPE supply chain, and contingency and/or crisis 534 capacity status for each hospital. Individualised risk assess-535 ment for each patient and sound clinical judgment is encour-536 aged, weighing the risk/benefits of delaying intervention 537 versus risk of patient and staff infection with COVID-19, 538 and the use of precious PPE resources. 539 From March 25, 2020, Australian Prime Minister Scott 540 Morrison cancelled all (public and private) non-urgent sur-541 gical procedures regardless of COVID-19 risk. Given the 542 potential for rapid dissemination of COVID-19 throughout 543 the health system, we recommend delaying non-urgent elec-here are intended to apply to out-552 patient procedures. Inpatients procedures required to facili-553 tate discharge and/or to avoid emergency department/ 554 hospital readmissions should be performed as quickly as 555 possible, if deemed urgent. If inpatient procedures are not 556 deemed urgent or critically necessary and can be deferred for 557 a minimum of 1-3 months, early discharge is recommended. 558 More frequent telehealth follow-up (e.g. weekly or monthly) 559 may be needed to ensure that clinical stability is maintained 560 in such patients, and to avoid ED presentations and hospital 561 readmissions. The definition of what constitutes an elective/non-urgent 562 case is based on a patient-specific risk assessment. The ratio-563 nale for delaying elective/non-urgent case procedures should 564 be discussed with the patient and documented in the medical 565 record. During the current pandemic, discussion amongst local 566 peers is recommended in borderline cases. Where possible, 567 same day discharges, are encouraged. Factors not directly 568 relating to the individual patient, such as PPE/other equip-569 ment or allied health staff availability and the ability of the 570 hospital to manage non COVID-19 patients at a particular point 571 in time may also affect the decision-making process, and 572whether to proceed to an elective procedure.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Pacemaker generator replacement for pacing-dependent 589 patients who are at elective replacement indicator (ERI) 590 or at device end of life (EOL). 591 5 Defibrillator generator replacements in those with previ-592 ous appropriate defibrillator therapies who are at EOL. 593 6 Catheter ablation of supraventricular arrhythmias caus-ablation for medically-refractory, ventricular 604 arrhythmia storm on a case-by-case basis, as determined 605 by the consensus of experts at the specialist centre for the 606 management of ventricular arrhythmias.* 607 9 Transvenous lead extraction on a case-by-case basis, as 608 determined by the consensus of experts at the specialist 609 accredited centres, taking into account the relative risks 610 of an invasive vs semi-invasive or conservative approach, 611 and the resource use implications and ancillary support 612 teams (e.g. cardiac surgical backup, anaesthesia, inten-613 sive care) required to carry out such a procedure. 614 *Ventricular arrhythmia storm includes sustained mono-615 morphic ventricular tachycardia (VT) or premature ventricular 616 complex (PVC)-induced ventricular fibrillation (VF). Storm is 617 defined as sustained VT lasting >12 hours or 3 episodes of VT 618 within 24 hours. Decisions regarding ablation of ventricular 619 arrhythmia storm need to be taken in the context of the patient's 620 overall mortality risk, the personnel and equipment burden on 621 the health care system during such procedures, and the risk of 622 managing potential complications of the procedure. Proce-623 dures on patients that may require a significant period in an 624 intensive care unit (ICU) should be avoided. writing committee acknowledges that there are many 628 other procedures that are considered ''semi-urgent\", and that 629 clinical judgement of the EP physician, in partnership with 630 the patient and the associated health care teams be exercised 631 in deciding whether to perform these procedures or delay 632 them for 1-3 months. Examples of such procedures, in agree-633 ment with Heart Rhythm Society COVID-19 Task Force com-634 mittee guidelines [1], are: 635",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "separate single-centre retrospective analysis, also from 765 Wuhan, demonstrates correlation between underlying car-766 diovascular disease (CVD) and myocardial injury with 767 increased mortality and malignant arrhythmias. One third 768 of the patients (35.3%) had previous CVD, and 52 (27.8%) 769 patients experienced an acute myocardial injury. Troponin T TnT) elevation likely represents myocardial injury from 771 either myocarditis, infarction with plaque rupture or diffuse 772 ischaemia from hypoxia. Mortality among patients with CVD 773 and elevated TnT levels was 69.44% (25 of 36), compared to 774 7.62% (8 of 105) among patients without CVD and acute 775 myocardial injury. Patients with CVD were more prone to 776 TnT elevation (54.5% vs 13.2%), and patients with elevated 777 TnT had more frequent malignant arrhythmias. The overall 778 incidence of VT or VF in this cohort of sick patients with 779 frequent underlying CVD (and a total mortality of 23%) was 780 5.9%. VT/VF was much more likely in the group with ele-781 vated TnT (17.3% vs 1.5%). Events of asystole were not 782 described [12]. These preliminary reports suggest greater 783 incidence of malignant arrhythmias among COVID-19 784 patients compared to SARS (2003). 785 Potential drug therapies for SARS-CoV-2 may exacerbate 786 cardiac arrhythmias. Hydroxychloroquine has been touted 787 as a possible agent which might reduce the severity of or 788 prevent infection [13]. Hydroxychloroquine (Plaquenil) is a 789 chloroquine derivative and, like all the related drugs in this 790 group, may cause QRS widening and QT interval prolonga-791 tion. However, it is safer to use than chloroquine. Cases of 792 torsades de pointes secondary to this drug are published. The 793 half-life of the drug is very long, and the risk is related to 794 either over dosage acutely or high dose long-term usage. 795 Hydroxychloroquine is being used in combination with 796 the antimicrobial azithromycin in clinical trials and shown 797",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "recent article from the Mayo Clinic suggested that the 803 risk of drug-induced Torsade de Points (DI-TdP) and/or 804 drug-induced sudden cardiac death (DI-SCD) can be miti-805 gated with some precautions. Baseline ECG and individual 806 patient assessment for addition risk factors for QTc prolonga-807 tion is indicated. Congenital (or inherent tendency for drug 808 induced QTc prolongation), modifiable or non-modifiable",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "1 We recommend mandatory training of all staff involved",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "period. This could include tasks such as designing and and development of educational resources. This will have a positive long-term impact on patient care after re-establishment of normal routines as the pandemic subsides. Furtherpatients. This will allow preservation of staff to provide case295 coverage if other members are affected. Practical Considerations for Lab Move all unnecessary EP equipment and cables out of the lab and into a designated storage area/on a trolley which can be accessed, if needed for a procedure. Remove all unnecessary items out of the control room such as spare cables, folders, storage discs, papers, posters etc. Create individual ECG dot packets to be taken in per Cleaning of main contact areas in the control room on a regular basis and/or between patients when necessary including but not limited to keyboards, mouse, phone, screens, door handles, light switches etc., using cleaning solutions known to be active against COVID-19, as per Follow-Up of Patients With CIED Management of patients requiring follow up for device therapy during the COVID-19 pandemic needs to address a 325 c High risk of significant adverse impact of delayed or missed review appointments in selected patients. Remote monitoring is a powerful tool for the management of patients with implanted devices. Although COVID-19 is spread primarily through respiratory droplets and close contact with an infected person, the virus may also be spread by contact with contaminated surfaces. Each of the networks should consult with their hospital's infection control or COVID-19 task force regarding recommended cleaning. Practices operating out of private consulting rooms should follow the guidelines of their nearest academic hospital that has an established infection control service.The aim of these recommendations is to reduce patient, 21 In the event of end-of-life management of a patient with terminal disease with or due to COVID-19 and an ICD in situ, consider asking the treating team to secure a clinical magnet to the skin over the ICD where possible, rather than using the programmer. ICD deactivation cannot be",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "criteria listed in ''urgent elective procedures\". Atrial arrhythmia ablation in stable patients without heart failure, not at significant risk of getting hospitalised by delaying the procedure or at high risk for procedure-related complications due to comorbidities.Type I AV block, other stable non-high degree AV block, or tachy-brady syndrome in mildly symptomatic patients. Extraction of non-infected devices/leads unless device function is dependent on lead extraction and re-implant.10 Left atrial appendage closure.11 Implantable loop recorder implants.12 Tilt-table testing. We consider CIED implants to be, at least, moderate risk of transmission to staff. We recommend categorising patients as per CSANZ interventional guidelines prior to the procedure (low, intermediate and high risk) [2], and utilising PPE as per local hospital protocol, with all staff involved suiting up prior to procedure commencement and de-robing in the procedure room post-procedure. We advise only the minimum number of staff be present and, where feasible, to have two separate operating teams, to avoid loss of device facility if one team is Where indicated and possible, we advise against temporising and advocate a permanent device implantation.Implications of COVID-19The intention of this domain is to provide an updated information source on the arrhythmic implications of COVID-19.SummaryThe mechanisms of cardiac injury include myocarditis, hypoxaemia, and cytokine storm. Myocarditis may be associated with ECG changes and arrhythmias but detailed observations on arrhythmias specific to SARS-CoV-2 are limited.The large series published from the Wuhan infection epicentre in China by Wang and colleagues shows illustrative data of the severity of SARS-CoV-2 [5]. In this series, the complications included acute cardiac injury 7.2%, shock 758 8.7%, arrhythmias 16.7% and overall 26% of hospitalised patients required ICU care. Details on specific arrhythmias were not provided but were more common in ICU than non-ICU patients. Other smaller studies have demonstrated similar observations with the development of cardiomyopathy",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Please cite this article in press as: Kumar S, et al. Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia during the COVID-19 Pandemic: A Living Document. Heart, Lung and Circulation (2020), https://doi.org/10.1016/j.hlc.2020.04.001 QTc risk factors ought to be taken into consideration. Given COVID-19's pandemic nature, the small proportion of patients at risk of DI-TdP/DI-SCD represents a significant number of individuals who may experience a life-threatening adverse effect if these medications are accepted for postexposure prescription [16]. Rigorous investigation of modifiable risk factors for QTc prolongation and consecutive ECG is mandatory is such patients. No doubt other therapies are being assessed and include ual Turnbull, Paul Weatherley. mary this document was developed as a joint project with the American",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}